In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics.

Ågren, Richard; Betari, Nibal; Saarinen, Marcus; Zeberg, Hugo; Svenningsson, Per; Sahlholm, Kristoffer

Ågren, Richard; Betari, Nibal; Saarinen, Marcus; Zeberg, Hugo; Svenningsson, Per; Sahlholm, Kristoffer.

Afiliação

Ågren R; Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden.
Betari N; Department of Integrative Medical Biology, Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
Saarinen M; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.
Zeberg H; Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden.
Svenningsson P; Basal and Clinical Neuroscience, Institute of Psychiatry, King's College London, Psychology and Neuroscience, London, UK.
Sahlholm K; Department of Clinical Neuroscience, Karolinska Institutet, Solna, Sweden.

Int J Neuropsychopharmacol ; 26(9): 599-606, 2023 09 25.

Article em En | MEDLINE | ID: mdl-37549917

Assuntos

Antipsicóticos; Dopamina; Dopamina/metabolismo; Antipsicóticos/farmacologia; Receptores Acoplados a Proteínas G/agonistas; Piranos

Palavras-chave

Trace amine-associated receptor-1; dopamine D2 receptor; electrophysiology; luminescence measurements; serotonin 1A receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos / Dopamina Idioma: En Revista: Int J Neuropsychopharmacol Assunto da revista: NEUROLOGIA / PSICOFARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google